144 / 64
144
Antonio Jiménez-Pacheco
Análisis de una serie de 32 tumores del tracto urinario superior
CONCLUSION
Los tumores del tracto urinario superior son una entidad
poco frecuente, donde la urografía por tomografía computeriza-
da multidetector (UTCMD) se ha convertido en el gold estandar
de las exploraciones radiológicas en el diagnóstico y seguimiento
de este tipo de tumores.
El gold estandar del tratamiento de los tumores del TUS, in-
dependientemente de la localización del tumor, continúa siendo
la nefroureterectomía radical con rodete vesical, aunque la ciru-
gía conservadora de nefronas en sus diferentes técnicas, es en la
actualidad una buena alternativa en casos seleccionados.
A pesar de ser una casuística limitada, los resultados obteni-
dos son satisfactorios independientemente de la técnica quirúrgi-
ca empleada al ser la supervivencia libre de enfermedad en el pe-
riodo de seguimiento del 100% y la mortalidad cáncer-específica
del 0%.
REFERENCIAS
1.
Suriano F, Brancato T. Nephron-sparing management of upper
tract urothelial carcinoma. Rev Urol 2014; 16:21-28.
2.
Rouprêta M, Zigeunerb R, Palou A, et al. European guidelines
for the diagnosis and management of upper urinary tract
urothelial cell carcinoma 2011 update. Eur Urol 2011; 59:
584-94.
3.
Liatsikos EN, Dinlenc CZ, Kapoor R, Smith AD. Transitional-cell
carcinoma of the renal pelvis: ureteroscopic and percutaneous
approach. J Endourol 2001; 15:377-83.
4.
Rouprêt M, Babjuk M, Compérat E, et al. European guidelines
on upper tract urothelial carcinomas: 2013 update. Eur Urol
2013; 63:1059-71.
5.
Sverrisson EF, Kim T, Espiritu PN, et al. The merits of cytology
in the work up for upper tract urothelial carcinoma - a
contemporary review of a perplexing issue. Int Braz J Urol
2014; 40: 493-8.
6.
Visser O, Adolfsson J, Rossi S, et al. Incidence and survival of
rare urogenital cancers in Europe. Eur J Cancer 2012; 48:456-
64.
7.
Yakoubi R, Colin P, Seisen T, et al. Radical nephroureterectomy
versus endoscopic procedures for the treatment of localised
upper tract urothelial carcinoma: A meta-analysis and a
systematic review of current evidence from comparative
studies. Eur J Surg Oncol 2014; 40: 1629-34.
8.
Ristau BT, Tomaszewski JJ, Ost MC. Upper tract urothelial
carcinoma: Current treatment and outcomes. Urology 2012;
79: 749-56.
9.
Martín Martín S, Calleja Escudero J, Trueba Arguiñarena FJ,
Rivero Martínez MD, Sanz Ruiz A, Fernández del Busto E.
Tumores del tracto urinario superior. Nuestra experiencia.
Arch Esp Urol 2008; 61: 499-506.
10. Crivelli JJ, Xylinas E, Kluth LA, Rieken M, Rink M, Shariat SF.
Effect of smoking on outcomes of urothelial carcinoma: A
systematic review of the literature. Eur Urol 2014; 65: 742-54.
11. Fanigan R. Tumores uroteliales de las vías urinarias. En Wein
AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-
Walsh Urology. 9th ed. Buenos Aires: Editorial Médica
Panamericana; 2008. p: 1638-52.
12. Wan LJ, Wong YC, Huang CC, Wu CH, Hung SC, Chen HW.
Multidetector computerized tomography urography is more
accurate tan excretory urography for diagnosing transitional
cell carcinoma of the upper urinary tract in adults with
hematuria. J Urol 2010; 183: 48-55.
13. Cowan NC. CT urography for hematuria. Nature 2012; 9: 218-
26.
14. Wang LJ, Wong YC, Chuang CK, Huang CC, Pang ST. Diagnostic
accuracy of transitional cell carcinoma on multidetector
computerized tomography urography in patients with gross
hematuria. J Urol 2009; 181: 524-31.
15. Takahashi N, Glockner JF, Hartman RP, et al. Gadolinium
enhanced magnetic resonance urography for upper urinary
tract malignacy. J Urol 2010; 183: 1330-65.
16. Izquierdo Reyes L. Tumores del tracto urinario superior. Clin
Urolog 2012; 4: 7-16.
17. Messer J, Shariat SF, Brien JC, et al. Urinary cytology has a por
performance for predicting invasive or high-grade upper-tract
urothelial carcinoma. BJU Int 2011; 108(5): 701-5.
18. Mian C, Mazzoleni G, Vikoler S, et al. Fluorescence in situ
hybridisation in the diagnosis of upper urinary tract tumours.
Eur Urol 2010; 58: 288-92.
19. Jovanovic M, Soldatovic I, Janjic A, et al. Diagnostic value of
the nuclear matrix protein 22 test and urine cytology in upper
tract urothelial tumors. Urol Int 2011; 87: 134-7.
20. Waldert M, Karakiewicz PI, Raman JD, et al. A delay in radical
nephroureterectomy can lead to upstaging. BJU Int 2010; 105:
812-7.
21. Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG,
Tolley DA. Ureteroscopic and percutaneous management of
upper tract urothelial carcinoma (UTUC): systematic review.
BJU Int 2012; 110:614-28.
22. Rouprêt M, Traxer O, Tligui M, et al. Upper urinary tract
transitional cell carcinoma: recurrence rate after percutaneous
endoscopic resection. Eur Urol 2007; 51:709-14.
23. Rouprêt M, Harmon JD, Sanderson KM, et al. Laparoscopic
distal ureterectomy and anastomosis for management of
low-risk upper urinary tract transitional cell carcinoma:
preliminary results. Br J Urol 2007; 99:623-27.
24. Goel MC, Matin SF, Derweesh I, Levin H, Streem S, Novick
AC. Partial nephrectomy for renal urothelial tumors: clinical
update. Urology 2006; 67:490-5.
25. Giannarini G, Schumacher MC, Thalmann GN, Bitton
A, Fleischmann A, Studer UE. Elective management of
transitional cell carcinoma of the distal ureter: can kidney-
sparing surgery be advised? BJU Int 2007; 100(2): 264-8.
26. Rastinehad AR, Ost MC, Vanderbrink BA, et al. A 20-year
experience with percutaneous resection of upper tract
transitional carcinoma: is there an oncologic benefit with
adjuvant bacillus Calmette Guérin therapy? Urology 2009; 73:
27-31.
27. Iborra I, Solsona E, Casanova J, Ricos JV, Rubio J, Climent
MA. Conservative elective treatment of upper urinary tract
tumors: a multivariate analysis of prognostic factors for
recurrence and progression. J Urol 2003; 169: 82-5.
28. Thalmann GN, Markwalder R, Walter B, Studer UE. Long-term
experience with bacillus Calmette-Guerin therapy of upper
urinary tract transitional cell carcinoma in patients not eligible
for surgery. J Urol 2002; 168:1381-5.
29. Katz MH, Lee MW, Gupta M. Setting a new standards for